Blood cocaine and metabolite pharmacokinetics after cardiac arrest in a body-packer case

Human and Experimental Toxicology

Volumn 29, Issue 1, 2010, Pages 49-53

  De Prost, Nicolas ^a   Mégarbane, Bruno ^b   Questel, Frank ^a   Bloch, Vanessa ^b   Cantin Bertaux, Delphine ^a   Pourriat, Jean Louis ^a   Rabbat, Antoine ^a  

^a HÔTEL DIEU   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Body packer; Cocaine; Pharmacokinetics

Indexed keywords

COCAINE;

ADULT; ARTICLE; CASE REPORT; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; GASTROINTESTINAL TRACT; HEART ARREST; HUMAN; INTOXICATION; MALE; METABOLITE; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

COCAINE; COCAINE-RELATED DISORDERS; CRIME; HALF-LIFE; HEART ARREST; HUMANS; MALE; MIDDLE AGED; OVERDOSE; VASOCONSTRICTOR AGENTS;

EID: 74849131677     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327109354940     Document Type: Article

References (22)

1. McCarron MM, Wood JD The cocaine body packer syndrome. Diagnosis and treatment. JAMA 1983 ; 250: 1417-1420.
2. Wetli CV, Mittlemann RE The "body packer syndrome"-toxicity following ingestion of illicit drugs packaged for transportation. J Forensic Sci 1981 ; 26: 492-500.
3. de Prost N., Lefebvre A., Questel F., et al. Prognosis of cocaine body-packers. Intensive Care Med 2005 ; 31: 955-958.
4. Claffey M. Stampede of drug mules at Kennedy: after 9/11 lull, heroin and ecstazy busts soar. New York Daily News 2002, p. 5.
5. Traub SJ, Hoffman RS, Nelson LS Body packing-the internal concealment of illicit drugs. N Engl J Med 2003 ; 349: 2519-2526.
6. Veyrie N., Servajean S., Aissat A., Corigliano N., Angelakov C., Bouillot JL Value of a systematic operative protocol for cocaine body packers. World J Surg 2008 ; 32: 1432-1437.
7. Donovan JL, Malcolm RJ, Markowitz JS, DeVane CL Chiral analysis of D- and L-modafinil in human serum: application to human pharmacokinetic studies. Ther Drug Monit 2003 ; 25: 197-202.
8. Karch SB, Stephens B., Ho CH Relating cocaine blood concentrations to toxicity-an autopsy study of 99 cases. J Forensic Sci 1998 ; 43: 41-45.
9. Blaho K., Logan B., Winbery S., Park L., Schwilke E. Blood cocaine and metabolite concentrations, clinical findings, and outcome of patients presenting to an ED. Am J Emerg Med 2000 ; 18: 593-598.
10. Jufer RA, Walsh SL, Cone EJ Cocaine and metabolite concentrations in plasma during repeated oral administration: development of a human laboratory model of chronic cocaine use. J Anal Toxicol 1998 ; 22: 435-444.
11. Jufer RA Wstadik A., Walsh SL, Levine BS, Cone EJ Elimination of cocaine and metabolites in plasma, saliva, and urine following repeated oral administration to human volunteers. J Anal Toxicol 2000 ; 24: 467-477.
12. EA Barnes AJ, Gorelick DA, Boyd SJ, Cone EJ, Huestis MA Major and minor metabolites of cocaine in human plasma following controlled subcutaneous cocaine administration. J Anal Toxicol 2006 ; 30: 501-510.
13. Moolchan ET, Cone EJ, Wstadik A., Huestis MA, Preston KL Cocaine and metabolite elimination patterns in chronic cocaine users during cessation: plasma and saliva analysis. J Anal Toxicol 2000 ; 24: 458-466.
14. Cone EJ Pharmacokinetics and pharmacodynamics of cocaine. J Anal Toxicol 1995 ; 19: 459-478.
15. Karch SB Interpretation of blood cocaine and metabolite concentrations. Am J Emerg Med 2000 ; 18: 635-636.
16. Got P., Baud FJ, Sandouk P., Diamant- Berger O., Scherrmann JM Morphine disposition in opiate-intoxicated patients: relevance of nonspecific opiate immunoassays. J Anal Toxicol 1994 ; 18: 189-194.
17. Jeffcoat AR, Perez- Reyes M., Hill JM, Sadler BM, Cook CE Cocaine disposition in humans after intravenous injection, nasal insufflation (snorting), or smoking. Drug Metab Dispos 1989 ; 17: 153-159.
18. Mikami LR Wieseler S., Souza RL, et al. Five new naturally occurring mutations of the BCHE gene and frequencies of 12 butyrylcholinesterase alleles in a Brazilian population. Pharmacogenet Genomics 2008 ; 18: 213-218.
19. Wu MH, Chen P., Remo BF, Cook EH Jr, Das S., Dolan ME Characterization of multiple promoters in the human carboxylesterase 2 gene. Pharmacogenetics 2003 ; 13: 425-435.
20. Xu YQ, Crumb WJ Jr., Clarkson CW Cocaethylene, a metabolite of cocaine and ethanol, is a potent blocker of cardiac sodium channels. J Pharmacol Exp Ther 1994 ; 271: 319-325.
21. Wang JF, Yang Y., Sullivan MF, et al. Induction of cardiac cytochrome p450 in cocaine-treated mice. Exp Biol Med (Maywood) 2002 ; 227: 182-188.
22. Visser L., Stricker B., Hoogendoorn M., Vinks A. Do not give paraffin to packers. Lancet 1998 ; 352: 1352.